6,530 results match your criteria Contraception[Journal]


Study of contraceptive Mobile app fails to provide convincing findings.

Contraception 2019 Feb 13. Epub 2019 Feb 13.

green-ivf, Grevenbroich Endocrinology and IVF-Center & Department of Gynecology and Obstetrics University of Cologne (Director: Prof. Dr. Peter Mallmann).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.07.141DOI Listing
February 2019
1 Read

Factors associated with provision of depot medroxyprogesterone acetate to adolescents by U.S. health care providers.

Contraception 2019 Feb 11. Epub 2019 Feb 11.

Division of Reproductive Health, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA, United States, 30341. Electronic address:

Objective: Identify factors associated with healthcare providers' frequency of depot medroxyprogesterone acetate (DMPA) provision to adolescents.

Study Design: We analyzed data from surveys mailed to a nationally representative sample of public-sector providers and office-based physicians (n=1984). We estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of factors associated with frequent DMPA provision to adolescents in the past year. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2019.01.005DOI Listing
February 2019
1 Read

F5-peptide enhances the efficacy of the non-hormonal male contraceptive adjudin.

Contraception 2019 Feb 11. Epub 2019 Feb 11.

The Mary M. Wohlford Laboratory for Male Contraceptive Research, Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY 10065. Electronic address:

Objective: The bioavailability of the non-hormonal male contraceptive adjudin is low in rats due to the blood-testis barrier (BTB). This study was designed to examine if F5-peptide, an endogenously produced reversible BTB modifier, could enhance the bioavailability of adjudin to affect spermatogenesis and provide a contraceptive effect in rats while reducing systemic toxicity.

Study Design: We overexpressed F5-peptide in adult male rats (n=10 rats; with 3 or 4 rats for each of the three different experiments noted in the three regimens) by intratesticular injection of a mammalian expression vector pCI-neo (pCI-neo/F5-peptide) vs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2019.01.007DOI Listing
February 2019
1 Read
2.335 Impact Factor

Looking back while moving forward: A justice-based, intersectional approach to research on contraception and disability.

Contraception 2019 Feb 11. Epub 2019 Feb 11.

Georgia State University.

For the first time in the twenty-first century, we have an emerging body of research regarding contraceptive use among adult women with disabilities in the United States. We highlight key findings from population-based analyses that found higher odds of female sterilization and lower odds of long-acting reversible contraception (LARC) use among women with disabilities compared to their peers without disabilities. We consider potential reasons underlying these differences, including discriminatory attitudes and policies that restrict the sexual and reproductive autonomy of people with disabilities. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2019.01.006DOI Listing
February 2019
1 Read

Claims for contraceptive services among young women filling chronic opioid prescriptions.

Contraception 2019 Feb 11. Epub 2019 Feb 11.

Division of Pharmaceutical Evaluation and Policy, Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address:

Objective: To describe claims for contraceptive services among reproductive aged women filling chronic opioid prescriptions.

Study Design: Using a large US commercial claims database, IMS Lifelink+, we identified women aged 15-44years who filled chronic opioid prescriptions (defined as a 90day supply of opioids without a 30day gap over a 180day time period) and had continuous pharmacy and medical enrollment for at least 90days prior to and 180days following their index opiod prescription. After excluding women with any claims for pregnancy-related services, we describe claims for contraceptive prescriptions and used multivariable logistic regression to identify variables associated with women filling chronic opioids without any contraceptive claims. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824193001
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2019.01.004DOI Listing
February 2019
1 Read

Patient recommendations for PrEP information dissemination at family planning clinics in Atlanta, Georgia.

Contraception 2019 Jan 31. Epub 2019 Jan 31.

Department of Medicine, Emory University School of Medicine.

Objective: Family planning (FP) clinics are an ideal setting to disseminate information about pre-exposure prophylaxis (PrEP), but little is known about women's preferences for learning about PrEP in this setting.

Study Design: We surveyed 500 women seeking care at 4 FP clinics in Atlanta. Before their provider visit, participants completed an HIV-risk screener. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.008DOI Listing
January 2019
1 Read

Pharmacokinetics of the 1.5mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index.

Contraception 2019 Jan 28. Epub 2019 Jan 28.

Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York.

Objective: To assess the pharmacokinetics (PK) of levonorgestrel after 1.5mg oral doses (LNG-EC) in women with normal, obese and extremely obese body mass index (BMI).

Study Design: The 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2019.01.003DOI Listing
January 2019
3 Reads

Pregnancy outcomes after removal of osmotic dilators in patients who presented for second-trimester abortion.

Contraception 2019 Jan 25. Epub 2019 Jan 25.

Department of Obstetrics and Gynecology, University of Maryland, Baltimore, MD.

Objective: To report pregnancy outcomes and potentially related complications among thirteen patients who had osmotic dilators placed for second-trimester dilation and evacuation followed by subsequent removal with the intention to continue their pregnancies.

Study Design: We reviewed billing and scheduling data between 2005 and 2017 to identify the total number of women seen for D&E and to identify the individuals who had dilators placed without a subsequent scheduled dilation and evacuation. We then performed chart reviews to determine pregnancy outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.09.007DOI Listing
January 2019
2 Reads

Effect of Staff Training and Cost Support on Provision of Long-Acting Reversible Contraception in Community Health Centers.

Contraception 2019 Jan 24. Epub 2019 Jan 24.

Divisions of Clinical Research & Family Planning, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, 4901, Forest Park, Avenue, Mailstop: 8064-37-1005St. Louis, Missouri 63108. Electronic address:

Objective: To compare the proportion of women receiving same-day long-acting reversible contraception (LARC) between two different models of contraceptive provision adapted from the Contraceptive CHOICE Project.

Study Design: We used a controlled time-trend study design to compare 502 women receiving structured contraceptive counseling in addition to usual care ("Enhanced Care") to 506 women receiving counseling plus healthcare provider education and cost support for LARC ("Complete CHOICE") at three federally qualified health centers. We provided funds to health centers to ensure an "on-the-shelf" supply and no-cost LARC for uninsured women. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824193000
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.12.005DOI Listing
January 2019
7 Reads

Uptake of Permanent Contraception among Women in Sub-Saharan Africa: A Literature Review of Barriers and Facilitators.

Contraception 2019 Jan 24. Epub 2019 Jan 24.

Morehouse School of Medicine, Atlanta, GA, USA; Healthy Sunrise Foundation, Las Vegas, NV, USA.

Objective: Uptake of permanent contraception among women remains low in sub-Saharan Africa compared to other regions. We aimed to synthesize available evidence on barriers to and facilitators of tubal ligation among women in sub-Saharan Africa.

Study Design: We reviewed literature on permanent contraception (tubal ligation) among women published between January 1, 2000 and October 30, 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.007DOI Listing
January 2019
2 Reads

A sensitive and robust UPLC-MS/MS method for quantitation of estrogens and progestogens in human serum.

Contraception 2019 Jan 24. Epub 2019 Jan 24.

Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA. Electronic address:

Objective: With the widespread use of sex-steroid hormones in contraceptives and hormone replacement therapy, there is an increasing need for reliable analytical methods. We report the development of a sensitive and robust UPLC-MS/MS method for quantitation of both endogenous and synthetic sex-steroid hormones in human serum.

Study Design: We developed and validated a UPLC-MS/MS method to quantify progestogens (etonogestrel, levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone) and estrogens (estradiol and ethinyl estradiol) with good accuracy, high sensitivity, and excellent robustness. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.010DOI Listing
January 2019
5 Reads

Shared Negative Experiences of Long-Acting Reversible Contraception and their Influence on Contraceptive Decision-Making: A Multi-Methods Study.

Contraception 2019 Jan 24. Epub 2019 Jan 24.

University of Chicago Medicine, Department of Obstetrics and Gynecology, Section of Family Planning and Contraceptive Research, 5841 S. Maryland Ave. - MC2050, Chicago, IL 60637.. Electronic address:

Objectives: We explored how negative stories about long-acting reversible contraception (LARC) - defined as a firsthand negative experience with LARC shared directly with the study participant - were involved in participants' decisions about whether to use LARC following abortion, and how counseling affected the influence of negative LARC stories on contraceptive choices.

Study Design: We performed a multi-methods study, embedded within a trial examining the impact of a theory-based counseling intervention on LARC uptake post-abortion. Participants completed a baseline survey to determine the influence of negative LARC stories. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2019.01.002DOI Listing
January 2019
2 Reads

Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.

Contraception 2019 Jan 23. Epub 2019 Jan 23.

Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14214, USA. Electronic address:

Objective: The objective was to evaluate the pharmacokinetics (PKs) of levonorgestrel (LNG)-containing combined oral contraceptives (COCs) in obese women.

Study Design: We pooled and reanalyzed data from 89 women with different body mass index (BMI) categories from four clinical studies. The LNG and ethinyl estradiol (EE) PKs were analyzed utilizing a zero-order absorption (K), two-compartment PK model to evaluate key PK parameters in relation to a range of weights, BMI and body surface area (BSA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.009DOI Listing
January 2019
3 Reads

Rebound of medication abortion in Texas following updated mifepristone label.

Contraception 2019 Jan 23. Epub 2019 Jan 23.

Texas Policy Evaluation Project, Austin, TX; Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, Oakland, CA.

Background: In 2013, Texas House Bill 2 (HB 2) placed restrictions on the use of medication abortion, which later were nullified with the 2016 FDA-approved mifepristone label.

Methods: Using data collected directly from Texas abortion facilities, we evaluated changes in the provision and use of medication abortion during three six-month time periods corresponding to the policy changes: before HB 2, after HB 2, and after the label change.

Results: Medication abortion constituted 28% of all abortions before HB 2, 10% after implementation of the restrictions, and 33% after the label change. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2019.01.001DOI Listing
January 2019
1 Read

Contraceptive use at first intercourse is associated with subsequent sexual behaviors.

Contraception 2019 Jan 23. Epub 2019 Jan 23.

Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address:

Objective: Women's contraceptive use at first sexual intercourse (FSI) may be associated with subsequent sexual behaviors. We examined associations between contraceptive methods used at FSI and subsequent number of lifetime partners, induced abortions and sexually transmitted infections (STIs).

Study Design: During 2011-2012, we collected questionnaire data from a random sample of women aged 18-45 years from Denmark, Norway and Sweden. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.006DOI Listing
January 2019
4 Reads

Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies.

Contraception 2019 Jan 10. Epub 2019 Jan 10.

Gynuity Health Projects, 220 East 42nd St., Suite 710, New York, NY 10017.

Objectives: Current service delivery models for second-trimester medical abortion typically include routine inpatient admission and overnight stays. To assess the feasibility of a day-service model, we evaluated outpatient administration of abortion medications and analyzed the proportion of clients who could avoid an overnight stay. We also examined additional key elements of medical abortion care to evaluate the practicality of this model. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.004DOI Listing
January 2019
2 Reads

One-year continuation of postpartum intrauterine contraceptive device: findings from a retrospective cohort study in India.

Contraception 2018 Dec 18. Epub 2018 Dec 18.

Jhpiego, an affiliate of Johns Hopkins University.

Objective: To evaluate outcomes of a national postpartum (within 48 h of delivery) copper intrauterine device placement (PPCuIUD) program in six "high-focus states" with high unmet family planning need in India.

Study Design: We identified high-volume district hospitals that provided PPCuIUD in six (Bihar, Jharkhand, Uttar Pradesh, Uttarakhand, Madhya Pradesh and Chhattisgarh) Indian states (two per state). Each selected hospital maintained a list of PPCuIUD acceptors with contact phone numbers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.003DOI Listing
December 2018
3 Reads
2.335 Impact Factor

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.

Contraception 2018 Dec 18. Epub 2018 Dec 18.

Department of Reproductive Health and Research, World Health Organization (WHO), Geneva, Switzerland. Electronic address:

Access to safe and effective contraceptive choices is a reproductive right and contributes tremendously to improvements in maternal and child health. Progestin-only injectables, particularly intramuscularly injected depot medroxyprogesterone acetate (DMPA-IM), have received increased attention given findings suggesting a potential association with increased HIV risk. For women at high risk of HIV, the World Health Organization's Medical eligibility criteria for contraceptive use currently aggregate recommendations for all progestin-only injectables, including DMPA-IM, subcutaneously injected DMPA (DMPA-SC) and intramuscularly injected norethindrone/ norethisterone enanthate (NET-EN), except in the case of some drug interactions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.001DOI Listing
December 2018
1 Read

Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies.

Contraception 2018 Dec 16. Epub 2018 Dec 16.

UCSF School of Pharmacy, Department of Clinical Pharmacy, 533 Parnassus Ave., U-503, Box 0622, San Francisco, CA 94143, USA. Electronic address:

Objectives: This study describes hormonal contraception services provided by pharmacists and characterizes patient populations utilizing the service at one supermarket-based pharmacy chain in California and Oregon.

Study Design: This is a descriptive study of 391 pharmacies in California and Oregon within a supermarket-based pharmacy chain providing hormonal contraception services and the patients who utilized those services in a 6.5-month period between August 2016 and February 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.12.002DOI Listing
December 2018
1 Read

Auricular acupuncture as an adjunct for pain management during first trimester abortion: a randomized, double-blinded, three arm trial.

Contraception 2018 Dec 7. Epub 2018 Dec 7.

Dept. of Obstetrics and Gynecology, Columbia University Irving Medical Center (CUIMC), NY, NY; Heilbrunn Dept. of Population & Family Health, Mailman School of Public Health, CUIMC. Electronic address:

Objectives: To assess pain-management using auricular acupuncture as an adjunct to ibuprofen and paracervical block during first trimester uterine aspiration, and to assess auricular acupuncture's effect on anxiety.

Study Design: This randomized, double-blinded, three-arm trial enrolled women undergoing uterine aspiration for spontaneous or induced abortion. Study participants were randomized 1:1:1 to receive auricular acupuncture, placebo, or usual care alone. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824183051
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.11.016DOI Listing
December 2018
14 Reads

A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs.

Contraception 2018 Dec 4. Epub 2018 Dec 4.

Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York City, NY 10032, USA. Electronic address:

Objectives: We explored levonorgestrel (LNG) concentrations, bleeding patterns and endometrial thickness in women with epilepsy (WWE) initiating an LNG-intrauterine device (IUD) co-administered with antiepileptic drugs (AEDs).

Study Design: This pilot study included 20 WWE ages 18 to 45 years with well-controlled seizures and stable AED regimens initiating a 52-mg LNG-IUD (20 mcg/d initial release). We collected blood and measured endometrial thickness before IUD placement and 21 days, 3 months and 6 months thereafter. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.018DOI Listing
December 2018
3 Reads

Retraction notice to "Maintaining rigor in research: flaws in a recent study and a reanalysis of the relationship between state abortion laws and maternal mortality in Mexico" [Contraception 95/1 (2017) 105-111].

Contraception 2019 01;99(1):71

Center for Health Systems Research, National Institute of Public Health, Av. Universidad 655, Cuernavaca, Morelos, Mexico; Institute for Health Metrics and Evaluation, University of Washington, 2301 5th Ave Suite 600, Seattle, WA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824183051
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.11.017DOI Listing
January 2019
13 Reads

How soon is too soon or watch the donut not the hole.

Authors:
Anita L Nelson

Contraception 2019 Jan;99(1):70

Western University of Health Sciences. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.09.005DOI Listing
January 2019
2 Reads

Changes in the use of effective and long-acting reversible contraception in Vietnam.

Contraception 2018 Nov 30. Epub 2018 Nov 30.

The Ohio State University (OSU), College of Public Health (CPH), Division of Epidemiology, Cunz Hall, 1841 Neil Avenue, Columbus, OH, 43210, USA. Electronic address:

Objectives: To calculate the prevalence and identify correlates of unmet need for contraception and to assess whether prevalence of use of effective contraception and long-acting reversible contraception (LARC) has changed over time among married or cohabiting, reproductive-age women in Vietnam.

Methods: Study population was drawn from nationally representative Multiple Indicator Cluster Surveys conducted in 2000, 2006, 2011 and 2014. Unmet need for contraception was defined as occurring when a fecund, married or cohabiting woman is not using any method of contraception but either does not want children or wants to delay birth for at least 1 year or until marriage. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.014DOI Listing
November 2018
2 Reads

Quantifying disparities in access to public-sector abortion based on legislative differences within the Mexico City Metropolitan Area.

Contraception 2018 Nov 28. Epub 2018 Nov 28.

National Institute of Public Health, Center for Population Health Research, Cuernavaca, Morelos, Mexico; Department of Obstetrics & Gynecology, Oregon Health & Science University & OHSU-PSU School of Public Health, Portland, OR, USA. Electronic address:

Objectives: In the Mexico City Metropolitan Area, only women in the city center have local access to legal first-trimester abortion. We quantify how this legislative discrepancy affects access to legal, public-sector abortion across the metropolitan area.

Study Design: In this observational study, we used a dataset representing 67. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824183051
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.11.012DOI Listing
November 2018
10 Reads

Self-administered lidocaine gel for local anesthesia prior to osmotic dilator placement: a randomized trial.

Contraception 2018 Nov 27. Epub 2018 Nov 27.

Stanford University, Department of Obstetrics and Gynecology, Division of Family Planning Services and Research, 300 Pasteur Drive, HG 332, Palo Alto, CA, USA 94305. Electronic address:

Objective(s): To compare pain scores during cervical dilator placement prior to dilation and evacuation (D&E) with patient-administered vaginal lidocaine gel versus lidocaine paracervical block (PCB).

Study Design: We conducted an unblinded randomized trial of women ≥18 years of age undergoing surgical abortion at ≥16 weeks' gestation in two outpatient clinics. We randomized participants to receive self-administered lidocaine gel 2% 20 mL intravaginally 15-30 min before procedure initiation or lidocaine 1% 12 mL PCB immediately prior to dilator placement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.013DOI Listing
November 2018
4 Reads

Prospective quantification of Fetomaternal hemorrhage with dilation and evacuation procedures.

Contraception 2018 Nov 27. Epub 2018 Nov 27.

Department of Obstetrics and Gynecology; University of California, Davis; 4860, Y Street, Suite 2500; Sacramento, CA, USA. Electronic address:

Objective: To describe fetomaternal hemorrhage (FMH) during second trimester dilation and evacuation (D&E) to evaluate if Rh-immune globulin (RhIG) 100 mcg (used in the United Kingdom) and 300 mcg (used in the United States) provide adequate prophylaxis.

Study Design: We conducted an exploratory prospective descriptive study of women undergoing D&E between 15weeks 0days and 23weeks 6days gestation. Enrolled participants had Kleihauer-Betke testing on specimens obtained before and after D&E. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.015DOI Listing
November 2018
2 Reads

Misalignment of sexual and reproductive health priorities among older Latino adolescents and their mothers.

Contraception 2018 Nov 22. Epub 2018 Nov 22.

Women's and Gender Studies, University of Texas at El Paso, El Paso, TX, USA.

Objective: The study describes maternal and adolescent perspectives on sexual decision making and the role of mothers in shaping use of contraception for the prevention of unplanned pregnancies and sexually transmitted infections (STIs) among older Latino adolescents.

Study Design: Researchers used a semistructured interview guide to conduct focus group discussions with 21 mother-adolescent Latino dyads (n=42). Latino adolescents ages 17-19 were eligible for the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.011DOI Listing
November 2018
20 Reads

Predictors of postabortion contraception use in Cambodia.

Contraception 2018 Nov 22. Epub 2018 Nov 22.

London School of Hygiene and Tropical Medicine; School of Tropical Medicine and Global Health, Nagasaki University.

Objective: To evaluate which characteristics collected at the point of abortion are associated with contraceptive use over the extended postabortion period for women in Cambodia.

Methods: The study includes a cohort of 500 women who attended a Marie Stopes International Cambodia clinic for an induced abortion. The primary outcomes are use of effective contraception ≥80% of the time over the 4- and 12-month period postabortion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.010DOI Listing
November 2018
11 Reads

An in-depth analysis of the use of shared decision making in contraceptive counseling.

Contraception 2018 Nov 22. Epub 2018 Nov 22.

University of California, San Francisco, Department of Family and Community Medicine, 1001 Potrero Ave., San Francisco, CA 94110; University of California, San Francisco, Advancing New Standards in Reproductive Health, Bixby Center for Global Reproductive Health, 1330 Broadway, Suite 1100, Oakland, CA 94612; University of California, San Francisco, Department of Epidemiology & Biostatistics, 1001 Potrero Ave., San Francisco, CA 94110. Electronic address:

Objective(s): Shared decision making (SDM) has emerged as a useful tool to promote patient-centered communication and is highly applicable to contraceptive decision making. Little is known about how SDM is operationalized in contraceptive counseling. This study aimed to explore and describe how SDM is used in the contraceptive counseling context. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.009DOI Listing
November 2018
5 Reads

Steroid reservoir loss during removal of perforated Levonorgestrel 52 mg intrauterine device.

Contraception 2018 Nov 22. Epub 2018 Nov 22.

Department of Obstetrics and Gynecology, University of Illinois College of Medicine at Rockford, Rockford, IL 61107, USA.

A 22-year-old G1P1 Caucasian female had hysteroscopic removal of a perforated intrauterine device during which the steroid reservoir of the intrauterine device was lost. Isolated steroid reservoirs are radiolucent on plain film radiography. We located the reservoir in the peritoneal cavity with magnetic resonance imaging and removed it via laparoscopy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.10.010DOI Listing
November 2018
2 Reads

Effect of contraceptive choice on rapid repeat pregnancy.

Contraception 2018 Nov 22. Epub 2018 Nov 22.

Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104. Electronic address:

Objective: To describe the prevalence of rapid repeat pregnancy (RRP), defined as repeat pregnancy within 18 months of delivery, in a large health system and to determine the impact of contraceptive method on RRP.

Study Design: Retrospective cohort.

Results: The prevalence of RRP among patients who delivered in August 2014 (n=804) was 27. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824183049
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.11.008DOI Listing
November 2018
10 Reads

Changing disparities in teen birth rates and repeat birth rates in Georgia: implications for teen pregnancy prevention.

Contraception 2018 Nov 22. Epub 2018 Nov 22.

Jane Fonda Center, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA.

Objective: To understand teen birth trends in Georgia by racial and geographic factors.

Study Design: We analyzed overall birth and repeat teen birth rates by race, urban/rural status and adequacy of obstetric care from 2008 to 2016 using vital records from all Georgia counties.

Results: Overall birth rates among teens analyzed decreased dramatically in Georgia, from 45. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.007DOI Listing
November 2018
2 Reads

Cell phone ownership and modern contraceptive use in Burkina Faso: implications for research and interventions using mobile technology.

Contraception 2018 Nov 20. Epub 2018 Nov 20.

Department of Population Family and Reproductive Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, United States. Electronic address:

Objectives: With over 420 million unique cell phone subscribers in sub-Saharan Africa, the opportunities to use personal cell phones for public health research and interventions are increasing. We assess the association between cell phone ownership and modern contraceptive use among women in Burkina Faso to understand the opportunity to track family planning indicators using cell phone surveys or provide family planning interventions remotely.

Study Design: We analyzed data from a cross-sectional, nationally representative population-based survey of women of reproductive age in Burkina Faso, the Performance Monitoring and Accountability 2020 Round 4, which was conducted between November 2016 and January 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.006DOI Listing
November 2018
15 Reads

Incidence of uterine rupture in second-trimester abortion with gemeprost alone compared to mifepristone and gemeprost.

Contraception 2018 Nov 20. Epub 2018 Nov 20.

Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.

Objectives: To compare uterine rupture rates in women having a medical abortion receiving gemeprost alone to those receiving mifepristone plus gemeprost.

Study Design: We reviewed the records of women undergoing medical abortion at 13 0/7-23 6/7 weeks from January 2007 to December 2014 at a single center in Italy. Prior to January 2011, we used gemeprost 1 mg vaginally every 3 h up to a maximum of five doses. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.004DOI Listing
November 2018
3 Reads
2.335 Impact Factor

Barriers and outcomes associated with unfulfilled requests for permanent contraception following vaginal delivery.

Contraception 2019 Feb 19;99(2):98-103. Epub 2018 Nov 19.

University of Rochester Medical Center, 601 Elmwood Ave, Box 668, Rochester, NY 14642. Electronic address:

Objectives: To identify barriers to postpartum permanent contraception procedures after vaginal delivery and to explore contraceptive and reproductive outcomes of women who experience unfulfilled requests.

Study Design: We performed a retrospective cohort study of women requesting postpartum permanent contraception after vaginal delivery from 7/1/11 to 6/30/14 at Strong Memorial Hospital in Rochester, NY. We ascertained patient characteristics and outcomes through electronic medical records and birth certificate data search. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.005DOI Listing
February 2019
5 Reads

Impact of training level on postplacental levonorgestrel 52 mg intrauterine device expulsion.

Contraception 2019 Feb 16;99(2):94-97. Epub 2018 Nov 16.

Department of Obstetrics and Gynecology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH 44109. Electronic address:

Objective: To determine the association between provider training level and postplacental intrauterine device (IUD) outcomes following insertion instruction by email only.

Study Design: We conducted a single-center chart review of demographics, insertion and clinical outcomes within 6 months of delivery for 116 patients who underwent postplacental levonorgestrel 52 mg IUD placement from October 1, 2016, to March 31, 2017.

Results: We confirmed IUD retention, removal or expulsion in 87 of 116 (75. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351181PMC
February 2019
4 Reads

Support for and interest in alternative models of medication abortion provision among a national probability sample of U.S. women.

Contraception 2019 Feb 15;99(2):118-124. Epub 2018 Nov 15.

Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, Oakland, CA 94612, USA.

Objective: The objective was to assess women's personal interest in and support for three alternative models of medication abortion (MA) provision.

Study Design: Using an online survey of a U.S. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.10.007DOI Listing
February 2019
1 Read

Medical abortion in the late first trimester: a systematic review.

Contraception 2019 Feb 13;99(2):77-86. Epub 2018 Nov 13.

Oregon Health & Science University, Department of Obstetrics & Gynecology, 3181 SW Sam Jackson Park Rd, Portland, OR 97239.

Objective: To describe the efficacy, safety, and acceptability of medical abortion in the late first trimester.

Study Design: We searched PubMed and Cochrane databases for articles in any language that examined the success of medical abortion at gestational ages (>63 to≤84 days gestation). We sought articles that compared: medical abortion with surgical abortion at this gestational age, combination mifepristone and misoprostol and/or misoprostol alone); different dosages of misoprostol; different routes of misoprostol administration; frequency of dosing; and location of medical abortion (in health care facility vs. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824183048
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367561PMC
February 2019
11 Reads

A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea.

Contraception 2019 Feb 12;99(2):125-130. Epub 2018 Nov 12.

Reprovision Clinical Consultancy, Beethovengaarde 111, 5344, CE, Oss, The Netherlands. Electronic address:

Objective: To evaluate the effect of investigational vaginal rings containing nomegestrol acetate (NOMAC) plus 17β-estradiol (E2) or etonogestrel (ENG) plus E2 in women with moderate to severe primary dysmenorrhea.

Study Design: This was a Phase 2b randomized, placebo-controlled, multicenter, double-blind study. We randomized participants to one of five treatment groups: four hormonal rings and one placebo ring. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.10.009DOI Listing
February 2019
4 Reads

Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.

Contraception 2019 Feb 12;99(2):137-141. Epub 2018 Nov 12.

Ministère de la Santé et de l'Action Sociale, Dakar, Senegal.

Objectives: The primary objective of this study was to compare the 12-month continuation rate for women who self-injected subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) with that for women receiving intramuscular depot-medroxyprogesterone acetate (DMPA-IM) from a provider. This research contributes to the broader goal of identifying solutions to support women to use contraception for their full desired duration.

Study Design: Participants were clients from 13 clinics in the Dakar and Thiés regions of Senegal who had decided to use injectable contraception prior to enrollment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.11.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367564PMC
February 2019
3 Reads

Hormonal contraception, breastfeeding and bedside advocacy: the case for patient-centered care.

Contraception 2019 Feb 10;99(2):73-76. Epub 2018 Nov 10.

University of North Carolina School of Medicine, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine; Carolina Global Breastfeeding Institute, Gillings School of Public Health.

Postpartum contraceptive decision making is complex, and recommendations may be influenced by breastfeeding intentions. While biologically plausible, concerns about the adverse impact of hormonal contraception on breast milk production have not been supported by the clinical evidence to date. However, the data have limitations, which can lead providers with different priorities around contraception and breastfeeding to interpret the data in a way that advances their personal priorities. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824183048
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.10.011DOI Listing
February 2019
12 Reads

The effect of immediate postpartum levonorgestrel contraceptive implant use on breastfeeding and infant growth: a randomized controlled trial.

Contraception 2019 Feb 6;99(2):87-93. Epub 2018 Nov 6.

University of California, San Francisco, Department of Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California.

Objective: This study assessed whether immediate postpartum insertion of levonorgestrel contraceptive implants is associated with a difference in infant growth from birth to 6 months, onset of lactogenesis, or breastfeeding continuation at 3 and 6 months postpartum compared to delayed insertion at 6 to 8 weeks postpartum.

Study Design: We conducted a randomized trial of women in Uganda who desired contraceptive implants postpartum. We randomly assigned participants to receive either immediate (within 5 days of delivery) or delayed (6 to 8 weeks postpartum) insertion of a two-rod levonorgestrel contraceptive implant system. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.10.008DOI Listing
February 2019
6 Reads

Reporting sterilization as a current contraceptive method among sterilized women: lessons learned from a population with high sterilization rates, Rajasthan, India.

Contraception 2019 Feb 31;99(2):131-136. Epub 2018 Oct 31.

Indian Institute of Health Management Research.

Objective: Measuring current use of contraception relies on self-reported responses from survey respondents. Reporting validity may be affected by women's interpretation of the question and may vary by background characteristics of women. The study aims to understand levels and patterns of underreporting of female sterilization in a population with high sterilization rates. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.10.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367562PMC
February 2019
2 Reads

Cognitive interviews to improve a patient-centered contraceptive effectiveness poster.

Contraception 2018 Dec 7;98(6):528-534. Epub 2018 Jul 7.

Department of Health Policy and Management, University of North Carolina at Chapel Hill, 135 Dauer Drive, 1101 McGavran-Greenberg Hall, CB #7411, Chapel Hill, NC, 27599-7411, United States.

Objectives: To refine the Centers for Disease Control and Prevention (CDC)'s contraceptive education poster using patient-centered design.

Study Design: We conducted cognitive interviews with 26 women aged 18-44 living in North Carolina who spoke and read English and had ever had sex. We interviewed women about both a CDC and a patient-centered poster in alternating order. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824183023
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.06.010DOI Listing
December 2018
8 Reads

Access to emergency contraception in Kansas City clinics.

Contraception 2018 Dec 3;98(6):482-485. Epub 2018 Jul 3.

University of Kansas School of Medicine.

Objective: To assess the accessibility of ulipristal acetate (UPA) and copper intrauterine devices (IUDs) for emergency contraception (EC) in reproductive health centers in the Kansas City metropolitan area.

Study Design: Using a secret shopper method, two female investigators called the reproductive health centers listed as EC providers on the nonprofit website bedsider.org that were located within 25 miles of the University of Kansas Medical Center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.06.011DOI Listing
December 2018
4 Reads

Feasibility study of family planning services screening as clinical decision support at an urban Federally Qualified Health Center network.

Contraception 2019 Jan 15;99(1):27-31. Epub 2018 Oct 15.

The Institute for Family Health, 2006, Madison, Avenue, NY, NY 10035. Electronic address:

Objective: The objective was to assess the feasibility of an intervention introducing family planning services screening clinical decision support to improve provision of contraception and/or preconception services for women of reproductive age in our primary care Federally Qualified Health Center (FQHC) network.

Study Design: We implemented a family planning services screening prompt for support staff to ask women 13-44 years at nonobstetric visits at specified time intervals. The response was displayed in the electronic medical record for the provider to review, linked to a documentation tool. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.10.004DOI Listing
January 2019
1 Read

Response to "study of contraceptive mobile app fails to provide convincing findings".

Contraception 2018 Oct 15. Epub 2018 Oct 15.

NaturalCycles Nordic AB, Luntmakargatan 26, S-111 37 Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00107824183045
Publisher Site
http://dx.doi.org/10.1016/j.contraception.2018.10.001DOI Listing
October 2018
12 Reads

"It's her body": low-income men's perceptions of limited reproductive agency.

Contraception 2019 Feb 15;99(2):111-117. Epub 2018 Oct 15.

Center for Research on Healthcare, University of Pittsburgh, 200 McKee Place, Suite 600, Pittsburgh, PA 15213, USA; Center for Women's Health Research and Innovation, University of Pittsburgh, 4200 Fifth Ave, Pittsburgh, PA 15260, USA; Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, University Drive (151C), Pittsburgh, PA 15240, USA.

Objectives: While some attention has been paid to men's contraceptive use and attitudes in international contexts, relatively little is known about the attitudes towards contraception and pregnancy of low-income, urban men in the U.S.

Study Design: We conducted semi-structured interviews with 58 low-income men in Pittsburgh, PA, to explore their perspectives on contraception, pregnancy, fatherhood, and relationships. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.contraception.2018.10.005DOI Listing
February 2019
1 Read